Gufic Biosciences Share Price
443.00+3.65 (+0.83%)
+22.14% past 1 Year
News
Gufic Biosciences rules out greenfield capex, limits spend to replacement needs
Equity
GUFICBIO
Gufic Biosciences maintains gross debt near Rs 400 crores for growth needs
Equity
GUFICBIO
Gufic Biosciences shares guidance for EBITDA margin expansion through FY2030
Equity
GUFICBIO
Gufic Biosciences projects steady annual improvement in gross margin profile
Equity
GUFICBIO
Gufic Biosciences issues revenue growth guidance indicating stronger FY performance outlook
Equity
GUFICBIO
Gufic Biosciences surges on getting nod to make further investment in Saraswat Co-operative Bank
Equity
GUFICBIO
Gufic Biosciences posts strong Q4 EBITDA growth with improved margins YoY
Equity
GUFICBIO
Gufic Biosciences Q4 FY earnings show strong profit and revenue growth
Equity
GUFICBIO
Gufic Biosciences gets nod to make further investment in Saraswat Co-operative Bank
Equity
GUFICBIO
Gufic Biosciences reports Profit after tax of 20.58 Crores, in the March 2026 quarter
Equity
GUFICBIO
Gufic Biosciences makes investment of $50,000 in Selvax
Equity
GUFICBIO
Gufic Biosciences invests USD 50,000 in Selvax Pty Ltd by acquiring 378,350 shares.
Equity
GUFICBIO
Gufic Biosciences reports Profit after tax of 15.56 Crores, in the December 2025 quarter
Equity
GUFICBIO
Gufic Biosciences Q3FY26 Earnings: Revenue Up 11%, EBITDA Growth 3.63%, PAT Down 19%.
Equity
GUFICBIO
Gufic BioSciences Q3FY26 Results: Revenue Up 11% YoY, Net Profit Down 19% YoY.
Equity
GUFICBIO
Gufic Biosciences targets strong export-led growth in injectables; Indore facility operational by FY26
Equity
GUFICBIO
Gufic Biosciences reports Profit after tax of 14.93 Crores, in the September 2025 quarter
Equity
GUFICBIO
Gufic Biosciences Q2 FY25 EBITDA declines YoY; EBITDA margin contracts on lower revenue.
Equity
GUFICBIO
Gufic Biosciences Q2 Net Profit and Revenue Update
Equity
GUFICBIO
Gufic Biosciences gains on making investment in Gufic Ireland
Equity
GUFICBIO